It was the largest qui tam ( whistleblower) settlement paid by a medical lab for manufacturing and distributing a faulty product. Quest Diagnostics set a record in April 2009 when it paid $302 million to the government to settle a Medicare fraud case alleging the company sold faulty medical testing kits.

2020: Acquires outreach laboratory service business of Memorial Hermann Health System, a non-for-profit health system in the Greater Houston region.

2019: Acquires clinical laboratory services business of Boyce & Bynum Pathology Laboratories, a provider of diagnostic and clinical laboratory services in the Midwest.

laboratory services business of Oxford Immunotec.

2017: Acquires Cleveland HeartLab, Inc.

2014: Acquires Solstas Lab Partners Group (and subsidiaries).

2011: Completes acquisition of Celera Corporation, a company that became famous by its sequencing of the Human Genome.

2011: Acquires Athena Diagnostics from Thermo Fisher Scientific.

2007: Acquires AmeriPath (and subsidiary Specialty Laboratories) from Welsh, Carson, Anderson & Stowe, becoming the leading provider of cancer diagnostic testing services.

2007: Completes acquisition of Sweden-based Hemocue, a point-of-care diagnostic testing company.

2006: Completes acquisition of Virginia-based Focus Diagnostics, Inc., an infectious and immunologic disease laboratory, for approximately $185 million in cash.

2005: Forms a strategic alliance with Ciphergen Biosystems to commercialize novel proteomic tests.

2005: Completes acquisition of Lenexa, Kansas-based LabOne, Inc., which includes the Employer Solutions drug testing division and the ExamOne paramedical testing division, ( Nasdaq: LABS) for approximately $934 million.

2003: Completes acquisition of California-based Unilab Corporation ( Nasdaq: ULAB) in a transaction valued at approximately $800 million.

(AML) and an affiliated company of AML, LabPortal, Inc., for approximately $500 million in cash.

2002: Completes acquisition of Virginia-based American Medical Laboratories, Inc.

( Nasdaq: MEDP), a healthcare technology company.

2001: Completes acquisition of Ohio-based MedPlus, Inc.

As of July 2020, Quest had performed more than 9.2 million COVID-19 molecular tests and 2.8 million serology tests. In March 2020, the company launched a COVID-19 testing service. In November 2018, Quest launched QuestDirect, a consumer-initiated testing service that allows patients to order health and wellness lab testing from home. In September 2018, Quest moved its headquarters from Madison, where it was located since 2007, to Secaucus, New Jersey. In May 2018, the company announced it will become an in-network laboratory provider to UnitedHealthcare starting in 2019, providing access to 48 million plan members.

īy the end of 2017, Quest, in partnership with Walmart, incorporated laboratory testing in about 15 of their locations in Texas and Florida. In 2016, Quest collaborated with Safeway to bring testing services to twelve of its stores in California, Maryland, Virginia, Texas and Colorado. Under Rusckowski, Quest Diagnostics teamed up with central New England's largest health care system, UMass Memorial Health Care, to purchase its clinical outreach laboratory. In response to Mohapatra's resignation after eight years with Quest, former Philips Healthcare CEO Stephen Rusckowski was appointed. In 2007 Quest acquired diagnostic testing equipment company AmeriPath. Steve Rusckowski, the chairman, president, and CEO of Quest Diagnostics at the World Economic Forum in 2017įrom May 2004 to April 2012, Surya Mohapatra served as the company's President and CEO. The purchase of SmithKline Beecham also included the lab's medical sample transport airline ( ICAO: LBQ, Call sign: LABQUEST) originally founded in 1988. Two years later in 1999, Quest added SmithKline Beecham Clinical Laboratories to their subsidiaries which includes a joint venture ownership with CompuNet Clinical Laboratory.

Over the next year, Quest acquired a clinical laboratory division of Branford, CT–based Diagnostic Medical Laboratory, Inc. Kenneth Freeman was appointed as CEO during this transition. On December 31, 1996, Quest Diagnostics became an independent company as a spin-off from Corning. By 1982, MetPath was acquired by what was then known as Corning Glass Works, and subsequently renamed Corning Clinical Laboratories. with headquarters in Teaneck, New Jersey. In 1969, the company's name changed to MetPath, Inc.

Brown, MD, the clinical laboratory underwent a variety of name changes. Originally founded as Metropolitan Pathology Laboratory, Inc., in 1967 by Paul A. Interior of a Patient Service Center in Franconia, Virginia 1960–1995

Call quest diagnostics directly